NRF2 Regulates HER2 and HER3 Signaling Pathway to Modulate Sensitivity to Targeted Immunotherapies

Hilal S. Khalil, Simon P. Langdon, Ibrahim H. Kankia, James Bown, Yusuf Y. Deeni

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)1-22
JournalOxidative Medicine and Cellular Longevity
Early online dateSep 2015
Publication statusPublished - 1 Jan 2016

Cite this